The invention is directed to compounds of Formula (I) useful as GPR40 agonists. Pharmaceutical compositions and methods of treating one or more conditions including, but not limited to, insulin resistance, hyperglycemia, obesity, diabetes such as NIDDM, and other disorders related to lipid metabolism, energy homeostasis, and complications thereof, using compounds of the invention are also described.
A compound represented by the following Formula (1):
wherein, Het
1
represents a bivalent five- or six-membered aromatic heterocyclic residue and may further be substituted; X
a
to X
d
each independently represent a heteroatom and may further be substituted; Y
a
to Y
f
each independently represent a heteroatom or a carbon atom and may further be substituted; the ring bound to Het
1
may have a double bond at any position
1,8-naphthyridinone compounds as modulators of an adenosine receptor are provided. The compounds may find use as therapeutic agents for the treatment of diseases mediated through a G-protein-coupled receptor signaling pathway and may find particular use in oncology.
A formed resin article, containing a compound and a polymer substance, wherein the compound has a maximum absorption wavelength in a range of 400 nm or less, measured in a solution of the compound,
wherein the compound is contained in the polymer substance in a quantity of 5 g/m2 or less, and
wherein a light transmittance of the article at a wavelength of 410 nm is 5% or less.
An ultraviolet absorbent composition, comprising:
at least one kind of ultraviolet absorbent (A) that is a compound represented by the following Formula (1); and
at least one kind of ultraviolet absorbent (B) that is a compound where absorbance at 320 nm is 20% or more of absorbance at absorption maximum wavelength in the range of from 270 nm to 400 nm and the absorption maximum wavelength is 380 nm or less:
wherein Het1 represents a bivalent five- or six-membered aromatic heterocyclic residue; the aromatic heterocyclic residue may have a substituent;
Xa, Xb, Xc and Xd each independently represent a heteroatom; Xa to Xd may have a substituent;
Ya, Yb, Yc, Yd, Ye and Yf each independently represent a heteroatom or a carbon atom; Ya to Yf may have a substituent; and
the rings bound to Het1 may have a double bond at any position.